§ Honest Comparison · Updated May 2026

PeptideRails vs AllayPay

AllayPay is a generalist high-risk processor that boards peptide merchants among many other categories. PeptideRails is built only for peptide brands. Here is what that difference means in practice.

§ Verdict

Pick PeptideRails if you want pricing transparency, a pre-underwritten backup acquirer, and peptide-specific underwriting. Pick AllayPay if you want cross-category coverage and don't mind quote-only pricing.

Feature-by-feature

Side-by-side comparison.

Feature	PeptideRails	AllayPay
Industry rate range	5–15% typical for peptide MIDs	5–15%
Pricing model	Statement-audited. Published savings vs. your current rate.	Quote-only, case-by-case
Reserve schedule	Statement-audited. Released on a published schedule.	Quote-only, typically 180 days
LegitScript bundled at cost	✓ Yes	— Pass-through
Two pre-underwritten backends	✓ Yes	— No
Peptide-specific underwriting	✓ Peptide-only by design	— Generalist high-risk
Boards MATCH-listed merchants	Yes, with documented cause + LegitScript	Yes (broad)
Onboarding (compliant merchant)	10 days	"Quick" (claimed)
Application fee	$0	Varies
Won't-board guarantee	If we can't lower your TCO, we won't board you	—

The honest assessment

Where each one actually wins.

PeptideRails wins on:

Pricing transparency. Statement-audited model means you see exact line-item deltas before signing.
Pre-underwritten backup acquirer. Every PeptideRails merchant has a warm secondary MID at a different bank. AllayPay uses a single acquirer per merchant.
Peptide-specific underwriting. We board only peptide brands and configure every account around BRAM. AllayPay is a generalist high-risk processor — their underwriting screen has to accommodate dozens of categories.
LegitScript at-cost. $1,075/year passed through with no markup, plus pre-screening to halve the certification cycle.
Onboarding speed. 10 days vs. industry-standard 4–6 weeks.

AllayPay wins on:

Cross-category coverage. AllayPay boards CBD, nutraceuticals, supplements, and several other high-risk categories. If your portfolio spans categories beyond peptides, AllayPay's breadth is useful.
Established brand. AllayPay has been in the high-risk space for years. If brand age is your decision criterion, that history matters.
Phone-first sales. AllayPay takes inbound sales calls before quoting. PeptideRails is web + email until you've seen your number.

Decision guide

Which one should you actually pick?

If you sell only peptides

PeptideRails. Peptide-specific underwriting and pricing transparency outweigh AllayPay's breadth.

If you sell peptides plus CBD or supplements

AllayPay. We don't board CBD. AllayPay's cross-category model is the better fit.

If you're on the MATCH list

Either will board you. PeptideRails requires documented cause + a LegitScript path. AllayPay is broader.

If working capital efficiency matters

PeptideRails. Our 90-day published reserve releases capital roughly 2× faster than the 180-day industry default.

Send us your current statement. We'll show you what you'd save.

Side-by-side analysis in your inbox within 24 hours. No phone calls. No application fee. If we can't lower your total cost of ownership in year one, we won't board you.

Get your quote → Send your statement